Furthermore, Ding et al. [23] reported that inhibition of miRNA-34a improves hepatic steatosis of mice by increasing the expression of Ppara and Sirt1, enhancing phosphorylation of AMPKα and, consequently, increasing lipid oxidation. The gene discussed is PPARA; the disease is Hepatic steatosis.